Tag: PHVS416
Positive Phase 2 Data from RAPIDe-1 Study of PHVS416 for the...
ZUG, Switzerland, March 18, 2023 (GLOBE NEWSWIRE) -- Pharvaris PHVS, a clinical-stage company developing novel, oral bradykinin-B2-receptor antagonists to treat and...